Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma
- 7 March 2008
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 44 (10) , 915-919
- https://doi.org/10.1016/j.oraloncology.2008.01.001
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Requirement of Epidermal Growth Factor Receptor for Hyperplasia Induced by E5, a High-Risk Human Papillomavirus OncogeneCancer Research, 2005
- Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancerInternational Journal of Cancer, 2005
- Human papillomaviruses in lymph node neck metastases of head and neck cancersActa Oto-Laryngologica, 2005
- Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck CancerJNCI Journal of the National Cancer Institute, 2004
- Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neckInternational Journal of Cancer, 2003
- Human Papillomavirus and head and neck cancer: Epidemiology and molecular biologyHead & Neck, 1998
- Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in NonsmokersJAMA Otolaryngology–Head & Neck Surgery, 1997
- Human papillomavirus (HPV) in head and neck cancerCancer, 1997
- Genetic progression model for head and neck cancer: implications for field cancerization.1996
- Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.Proceedings of the National Academy of Sciences, 1993